Natural Health Trends Reports Third Quarter 2024 Financial Results
| Date: | Wednesday, October 30, 2024 |
| Time: | 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time |
| Dial-in: | 1-877-407-0789 (Domestic) 1-201-689-8562 (International) |
| Conference ID: | 13749004 |
| Webcast: | |
For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on October 30, 2024 through 11:59 p.m. Eastern Time on November 6, 2024 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13749004.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company's website at
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company's actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption“Risk Factors” in Natural Health Trends Corp.'s Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED BALANCE SHEETS (In thousands, except share data) | |||||||
| September 30, 2024 | December 31, 2023 | ||||||
| (Unaudited) | |||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 22,899 | $ | 56,178 | |||
| Marketable securities | 23,429 | - | |||||
| Inventories | 3,684 | 4,293 | |||||
| Other current assets | 3,830 | 3,758 | |||||
| Total current assets | 53,842 | 64,229 | |||||
| Property and equipment, net | 205 | 266 | |||||
| Operating lease right-of-use assets | 2,784 | 3,319 | |||||
| Restricted cash | 38 | 39 | |||||
| Deferred tax asset | 307 | 369 | |||||
| Other assets | 1,115 | 869 | |||||
| Total assets | $ | 58,291 | $ | 69,091 | |||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 548 | $ | 990 | |||
| Income taxes payable | 5,032 | 3,716 | |||||
| Accrued commissions | 2,029 | 2,067 | |||||
| Other accrued expenses | 1,350 | 1,170 | |||||
| Deferred revenue | 6,832 | 6,166 | |||||
| Amounts held in eWallets | 3,458 | 3,945 | |||||
| Operating lease liabilities | 1,191 | 1,146 | |||||
| Other current liabilities | 672 | 784 | |||||
| Total current liabilities | 21,112 | 19,984 | |||||
| Income taxes payable | - | 5,054 | |||||
| Deferred tax liability | 135 | 135 | |||||
| Operating lease liabilities | 1,739 | 2,318 | |||||
| Total liabilities | 22,986 | 27,491 | |||||
| Stockholders' equity: | |||||||
| Preferred stock | - | - | |||||
| Common stock | 13 | 13 | |||||
| Additional paid-in capital | 84,865 | 84,695 | |||||
| Accumulated deficit | (24,216 | ) | (17,703 | ) | |||
| Accumulated other comprehensive loss | (960 | ) | (1,069 | ) | |||
| Treasury stock, at cost | (24,397 | ) | (24,336 | ) | |||
| Total stockholders' equity | 35,305 | 41,600 | |||||
| Total liabilities and stockholders' equity | $ | 58,291 | $ | 69,091 | |||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net sales | $ | 10,691 | $ | 10,615 | $ | 32,117 | $ | 32,987 | |||||||
| Cost of sales | 2,765 | 2,689 | 8,376 | 8,386 | |||||||||||
| Gross profit | 7,926 | 7,926 | 23,741 | 24,601 | |||||||||||
| Operating expenses: | |||||||||||||||
| Commissions expense | 4,333 | 4,361 | 13,022 | 13,861 | |||||||||||
| Selling, general and administrative expenses | 3,868 | 3,857 | 11,597 | 12,169 | |||||||||||
| Total operating expenses | 8,201 | 8,218 | 24,619 | 26,030 | |||||||||||
| Loss from operations | (275 | ) | (292 | ) | (878 | ) | (1,429 | ) | |||||||
| Other income, net | 441 | 585 | 1,523 | 1,708 | |||||||||||
| Income before income taxes | 166 | 293 | 645 | 279 | |||||||||||
| Income tax provision | 131 | 121 | 249 | 69 | |||||||||||
| Net income | $ | 35 | $ | 172 | $ | 396 | $ | 210 | |||||||
| Net income per common share: | |||||||||||||||
| Basic | $ | 0.00 | $ | 0.02 | $ | 0.03 | $ | 0.02 | |||||||
| Diluted | $ | 0.00 | $ | 0.02 | $ | 0.03 | $ | 0.02 | |||||||
| Weighted average common shares outstanding: | |||||||||||||||
| Basic | 11,471 | 11,440 | 11,464 | 11,432 | |||||||||||
| Diluted | 11,490 | 11,454 | 11,488 | 11,449 | |||||||||||
| NATURAL HEALTH TRENDS CORP. CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (In thousands) | |||||||
| Nine Months Ended September 30, | |||||||
| 2024 | 2023 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||
| Net income | $ | 396 | $ | 210 | |||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||||
| Depreciation and amortization | 100 | 130 | |||||
| Net accretion of marketable securities | (350 | ) | - | ||||
| Share-based compensation | 109 | 123 | |||||
| Noncash lease expense | 825 | 830 | |||||
| Deferred income taxes | 62 | (117 | ) | ||||
| Changes in assets and liabilities: | |||||||
| Inventories | 619 | (420 | ) | ||||
| Other current assets | (110 | ) | (425 | ) | |||
| Other assets | (250 | ) | (92 | ) | |||
| Accounts payable | (441 | ) | (141 | ) | |||
| Income taxes payable | (3,738 | ) | (2,923 | ) | |||
| Accrued commissions | (34 | ) | (315 | ) | |||
| Other accrued expenses | 179 | (58 | ) | ||||
| Deferred revenue | 641 | 674 | |||||
| Amounts held in eWallets | (501 | ) | (725 | ) | |||
| Operating lease liabilities | (851 | ) | (812 | ) | |||
| Other current liabilities | (111 | ) | (148 | ) | |||
| Net cash used in operating activities | (3,455 | ) | (4,209 | ) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||
| Purchases of property and equipment | (37 | ) | (32 | ) | |||
| Purchases of marketable securities | (44,839 | ) | - | ||||
| Proceeds from maturities of marketable securities | 21,786 | - | |||||
| Net cash used in investing activities | (23,090 | ) | (32 | ) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||
| Dividends paid | (6,909 | ) | (6,911 | ) | |||
| Net cash used in financing activities | (6,909 | ) | (6,911 | ) | |||
| Effect of exchange rates on cash, cash equivalents and restricted cash | 174 | (145 | ) | ||||
| Net decrease in cash, cash equivalents and restricted cash | (33,280 | ) | (11,297 | ) | |||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period | 56,217 | 69,746 | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period | $ | 22,937 | $ | 58,449 | |||
| SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | 191 | $ | 115 | |||
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
...

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment